Revvity

Overview

Revvity, Inc. is a life sciences and diagnostics company that launched in 2023, building on its previous affiliation with PerkinElmer, Inc. The company aims to enhance human potential through science by offering innovative solutions that cover the entire biomedical workflow, from research discovery to diagnosis and treatment.

It provides a wide range of products and services, including reagents, consumables, assays, instruments, and software. These solutions support applications such as target discovery, preclinical development, clinical stratification, and specialty diagnostics, integrating automation and multi-omics technologies to facilitate decision-making in research and clinical environments. Revvity serves a diverse clientele, including pharmaceutical and biotechnology companies, diagnostic laboratories, academic institutions, and government agencies, emphasizing sustainability and advancing science to improve health outcomes worldwide.

Basic Information

Contact Details

• Phone: +1 781-663-6900
• Website: revvity.com
• LinkedIn: linkedin.com/company/revvity

Key Focus Areas & Initiatives

• Biotechnology research
• Laboratory analytical instruments
• Software solutions
• Liquid handling automation
• Clinical diagnostics
• Diagnostic instruments
• Drug development
• Multi-omics technologies
• Healthcare innovation
• Molecular diagnostics
• Reagents & consumables
• Genetic and genomic testing
• Biomarker discovery & screening
• Automation platforms
• Data analytics in healthcare
• Precision medicine
• Clinical research services
• Immunodiagnostics
• Next-generation sequencing automation

Technologies Used

• Akamai
• Amazon AWS
• Amazon CloudFront
• Amazon Elastic Load Balancer
• MailJet
• Microsoft Office 365
• NSOne
• Outlook
• Rackspace MailGun
• Remote
• Salesforce
• Zendesk

Affiliated Organizations & Regional Branches

• Revvity Signals